Corporate, Portfolio & Innovation Strategy

“We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio.”

“…And, because we’re technology led and industry deep, we’ve developed leading models, growth frameworks and scenario planning solutions that quickly bring business strategy to…”

“Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine their potential…”

“Our asset life cycle experts can help you navigate strategic growth and expansion opportunities at a corporate level or within specific therapeutic areas.”

“Our consultants facilitate strategic planning sessions to help your leadership team revise and adjust your corporate strategy, vision, and purpose to thrive in the ever-changing…”

“Our strategic consulting service offers business decision support for life science companies, including growth strategy, strategic market access support, and Business Development…”

“With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio Strategy, Licensing…”

“Strategy: Vision and goal setting, full potential realization and growth strategy, mid-/long-term TA strategy, and critical event strategy”

“Asset and development strategy, feasibility, and integrated evidence generation and planning.”

“…Beyond the Asset Decisions don’t happen in isolation. We help clients think across therapy areas and portfolios, identifying where science aligns, where unmet need clusters, and…”

“…Enhance your portfolio strategy and manage risk effectively with evidence-based decisions. Understand market dynamics, evaluate pipeline assets and prioritize products based on…”